Contract A207_PO-0443633-V3

The University of Virginia awarded contract A207_PO-0443633-V3 to BroadPharm on August 8, 2026, for the procurement of specialized biochemical materials. The contract encompasses the delivery of 350 units of BP-25757TCO-PEG2-DBCO (a pegylated dibenzocyclooctyne compound) at 50 milligrams per unit, valued at $350 in cumulative contract value. The line item specifies delivery to the Buyer, though the specific performance location is not detailed in the award documentation.

BroadPharm serves as the prime contractor for this procurement, which falls under the University of Virginia's purchasing authority. The contract represents a unit price arrangement of $1.00 per item. While the award date is documented as August 8, 2026, the contract documentation does not specify the period of performance or contract duration terms. This procurement appears to support the University's research or operational requirements for pegylated click chemistry reagents commonly utilized in bioconjugation applications.